🔗 Permalink

Assignee profile:

Volution Immuno Pharmaceuticals SA

City:

Geneva

Country:

Switzerland

Published Applications:

Last publication date:

2025-06-19

Patent Grants:

Last grant date:

2022-01-04

Top Inventors for applications by Volution Immuno Pharmaceuticals SA

These are the the leading inventors for applications assigned to Volution Immuno Pharmaceuticals SA:

Wynne Weston-Davies 3 Cheltenham, United Kingdom
John Hamer 3 London, United Kingdom
Wynne H. Weston-Davies 2 Salperton, United Kingdom
Miles Andrew Nunn 2 Geneve, Switzerland

Miles Andrew Nunn 2 Geneva, Switzerland
Yoshishige Miyabe 1 Brookline, MA United States
Andrew Luster 1 Wellesley, MA United States
Virginia Calder 1 London, United Kingdom

Brihad Abhyankar 1 Geneve, Switzerland
Miles Nunn 1 3 Geneve, Switzerland
Brihad Abhyankar 1 Geneva, Switzerland
Wynne H. Weston-Davies 1 Caine, United Kingdom

Christian David Sadik 1 Lubeck, Germany
Miles Andrew NUNN 1 Reading, United Kingdom
Miles Andrew Nunn 1 3 Geneve, Switzerland

Recent patent applications by Volution Immuno Pharmaceuticals SA

Volution Immuno Pharmaceuticals SA based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-19

US20250195612A1

Human necessities

Coversin for use in the treatment of rheumatic diseases

#2 | 2023-01-05

US20230002456A1

Chemistry; metallurgy

Coversin Variants Lacking C5 Binding

#3 | 2022-08-11

US20220249608A1

Human necessities

Method of Treating Peripheral Nerve Disorders

#4 | 2022-07-07

US20220211810A1

Human necessities

Method of Treatment

#5 | 2021-09-16

US20210283221A1

Human necessities

Ornithodoros Moubata Complement Inhibitor for Use in the treatment of Complement-Mediated Diseases in Patients with C5 Polymorphism

#6 | 2020-12-10 ✅ Patent 11,214,602 granted on 2022-01-04

US20200385434A1

Chemistry; metallurgy

Coversin variants lacking C5 binding

#7 | 2020-09-10

US20200282018A1

Human necessities

Method of Treating Myasthenia Gravis

#8 | 2020-04-16 ✅ Patent 11,730,792 granted on 2023-08-22

US20200113971A1

Human necessities

Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)

#9 | 2017-07-13 ✅ Patent 11,052,129 granted on 2021-07-06

US20170196936A1

Human necessities

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with C5 polymorphism

#10 | 2017-03-09

US20170065677A1

Human necessities

EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT

#11 | 2015-07-16 ✅ Patent 9,522,171 granted on 2016-12-20

US20150196619A1

Human necessities

EV576 for use in the treatment of viral infections of the respiratory tract

#12 | 2011-10-27 ✅ Patent 8,993,264 granted on 2015-03-31

US20110263482A1

Chemistry; metallurgy

Complement inhibitors

#13 | 2010-05-06 ✅ Patent 9,211,312 granted on 2015-12-15

US20100111929A1

Human necessities

Method of treating peripheral nerve disorders

Also check out VOLUTION IMMUNO PHARMACEUTICALS SA's (Geneva, Switzerland) applicant profile with 6 patent applications submitted.

AssigneeID:

119880 ⎘